Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
語言
全文檢索
題名
作者
主題
索引號
ISBN/ISSN
標簽
檢索
高級檢索
Phase-3 randomized trial of ev...
引用
發送短信
推薦此
打印
導出紀錄
導出到 RefWorks
導出到 EndNoteWeb
導出到 EndNote
Permanent link
Phase-3 randomized trial of everolimus (RAD001) vs. placebo in advanced pancreatic NET (RADIANT-3)
書目詳細資料
Main Authors:
Chambers, J
,
Reed, N
,
Mansoor, W
,
Ross, P
,
Grossman, A
格式:
Conference item
出版:
2010
持有資料
實物特徵
相似書籍
職員瀏覽
相似書籍
Adrenocortical Cancer: A Therapeutic Approach with Everolimus (RAD001)
由: Gueorguiev, M, et al.
出版: (2010)
Novel and evolving therapies in the treatment of malignant phaeochromocytoma: experience with the mTOR inhibitor everolimus (RAD001).
由: Druce, MR, et al.
出版: (2009)
Everolimus plus octreotide long-acting repeatable in patients with advanced lung neuroendocrine tumors: analysis of the phase 3, randomized, placebo-controlled RADIANT-2 study.
由: Fazio, N, et al.
出版: (2013)
Effect of Everolimus plus Octreotide LAR in Patients With Advanced Lung Neuroendocrine Tumours - Analysis From RADIANT-2
由: Fazio, N, et al.
出版: (2011)
The Rapamycin Derivative RAD001 (Everolimus) Inhibits Cell Proliferation and Interacts with the Akt-mTOR-p70S6K Pathway in Human Medullary Thyroid Carcinoma Cells
由: Grozinsky-Glasberg, S, et al.
出版: (2009)